Alterity Therapeutics (PRNAD) Profit After Tax (2009 - 2019)

Alterity Therapeutics (PRNAD) has reported Profit After Tax for 5 consecutive years, with -$7.8 million the latest figure, recorded in Q4 2019.

• In Q4 2019, Profit After Tax rose 3.44% year-over-year to -$7.8 million; the TTM figure through Dec 2019 stood at -$27.3 million (down 148.17% YoY), while the FY2025 annual figure was -$7.8 million, up 38.27% from the prior year.
• Profit After Tax came in at -$7.8 million for Q4 2019 at Alterity Therapeutics, up from -$8.1 million in the prior quarter.
• The five-year high for Profit After Tax was -$5.6 million in Q4 2016, with the low at -$8.1 million in Q4 2018.
• Average Profit After Tax over 4 years is -$6.8 million, with a median of -$6.8 million recorded in 2017.
• Across the five-year window, Profit After Tax tumbled 38.91% in 2018 and gained 3.44% in 2019, its largest moves.
• Year by year, Profit After Tax stood at -$5.6 million in 2016, then fell by 3.31% to -$5.8 million in 2017, then plunged by 38.91% to -$8.1 million in 2018, then increased by 3.44% to -$7.8 million in 2019.
• According to Business Quant data, Profit After Tax over the past three periods registered -$7.8 million, -$8.1 million, and -$5.8 million for Q4 2019, Q4 2018, and Q4 2017 respectively.